SuperworthKenvue KVUE
- Market cap
- $37.6B
- PE
- 22.5×
- 3y median 24.1×
- Forward PE
- 16.2×
- 3y median 18.5×
- Price to sales
- 2.4×
- EV/EBIT
- 14.3×
- Revenue, 12 months
- $15.4B
- +2% on a year ago
- Net margin
- 10.8%
- Free cash flow yield
- 5.1%
Kenvue trades at 22.5× trailing earnings, cheaper than 77% of the last ten years. Revenue was $15.4B over the last twelve months, up 2% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.9B+3% | $3.7B−3% | $3.9B+1% | $4B−0% | $3.9B−0% | $3.7B−0% | $3.7B−4% | $3.8B−4% | $3.8B−4% | $3.8B+3% | $3.9B+5% | $4B+3% | |
| Cost of revenue | $1.7B+0% | $1.6B | $1.7B−4% | $1.6B−9% | $1.6B−3% | $1.6B−2% | $1.6B−5% | $1.6B−4% | $1.5B−5% | $1.6B+3% | $1.6B+2% | $1.7B+5% |
| Gross profit | $2.3B+6% | $2B−0% | $2.2B+6% | $2.4B+6% | $2.3B+1% | $2.1B+1% | $2.2B−3% | $2.3B−4% | $2.2B−3% | $2.1B+3% | $2.3B+6% | $2.3B+2% |
| SG&A | $1.5B+11% | $1.6B | $1.6B+5% | $1.6B+8% | $1.6B+4% | $1.5B−4% | $1.5B−2% | $1.5B−8% | $1.5B−5% | $1.5B+1% | $1.5B−6% | $1.5B+2% |
| $710M−7% | $460M | $550M−14% | $154M−78% | $654M−8% | $483M+5% | $558M+2% | $692M+349% | $629M−4% | $535M+11% | $767M+38% | $699M+1% | |
| Interest expense | $115M | $114M | $109M+891% | $106M−10% | $108M−6% | $108M−5% | $107M−2% | $107M+1% | $107M−1% | $109M+1% | $106M−1% | $103M−4% |
| Pre-tax income | $585M−21% | $357M−30% | $427M−30% | $65M−90% | $577M−1% | $346M−3% | $458M+7% | $588M+805% | $526M−9% | $427M+23% | $672M+47% | $598M+2% |
| $147M−3% | $30M−80% | $131M−6% | $7M−97% | $194M+32% | $53M+77% | $136M+4% | $168M+2300% | $128M−34% | $97M+83% | $198M+46% | $142M−16% | |
| Net income | $438M−25% | $327M−9% | $296M−37% | $58M−87% | $383M−13% | $293M−10% | $322M+9% | $420M+624% | $398M+4% | $330M+13% | $474M+47% | $456M+9% |
| $0.23−32% | $0.17−19% | $0.15−44% | $0.03−87% | $0.20−13% | $0.15−12% | $0.17+13% | $0.22+633% | $0.21+5% | $0.17+13% | $0.25+47% | $0.24+9% | |
| 1.9B+12% | 1.9B | 1.9B+12% | 1.9B+5% | 1.9B+0% | 1.9B+1% | 1.9B+0% | 1.9B+0% | 1.9B−0% | 1.9B−0% | 1.9B−0% | 1.9B−0% |
EPS, diluted: Q4 FY24 and Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 3 periods, Q4 FY23 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $3.9B | $3.9B to $3.9B | $0.29 | $0.27 to $0.33 | 6 |
| Q4 FY26 | $3.9B | $3.9B to $3.9B | $0.26 | $0.25 to $0.27 | 6 |
| Q1 FY27 | $4B | $4B to $4.1B | $0.33 | $0.32 to $0.34 | 4 |
| Q2 FY27 | $4.1B | $4B to $4.1B | $0.32 | $0.32 to $0.33 | 4 |
| Q3 FY27 | $3.9B | $3.9B to $4B | $0.30 | $0.30 to $0.31 | 4 |
| Q4 FY27 | $3.9B | $3.9B to $4B | $0.28 | $0.27 to $0.28 | 4 |
| Q1 FY28 | $4.1B | $4.1B to $4.2B | $0.35 | $0.34 to $0.36 | 3 |
| Q2 FY28 | $4.2B | $4.1B to $4.2B | $0.34 | $0.33 to $0.35 | 3 |
Peers
Companies in Household & Personal Products nearest Kenvue's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| KVUEKenvue | $37.6B | 22.5× | 24.1× | 16.2× | 2.4× | +2% | 10.8% |
| KMBKimberly-Clark | $36.6B | 18.7× | 21.4× | 15.8× | 2.2× | +1% | 11.8% |
| ELEstée Lauder Companies | $39.3B | 222× | 44.6× | 32.8× | 2.6× | +5% | 1.2% |
| CHDChurch & Dwight | $25B | 33.8× | 29.4× | 26.9× | 4.0× | +3% | 12.0% |
| CLColgate-Palmolive | $75B | 37.3× | 27.2× | 24.0× | 3.6× | +5% | 9.7% |
| AVYAvery Dennison | $13.8B | 19.9× | 23.4× | n/m | 1.5× | +6% | 7.6% |
| ELFe.l.f. Beauty | $6.7B | 114× | 69.2× | n/m | 3.8× | +31% | 3.4% |
| REYNReynolds Consumer Products | $4.9B | 14.0× | 17.6× | n/m | 1.3× | +3% | 9.1% |
| PGProcter & Gamble | $374.3B | 24.3× | 25.2× | 23.3× | 4.3× | +4% | 18.2% |
| Peer median | $30.8B | 29.0× | 26.2× | 24.0× | 3.1× | +4% | 9.4% |
Investors who own it
Investors we follow who held Kenvue at the end of Jun 30, 2026, from their 13F filings.
- Lee AinslieMaverick Capital0.0% of portfolioadded
More on Kenvue
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #6of 24Consumer staples stocks with the highest dividend yields
- #4of 15Household and personal products stocks with the lowest EV/EBIT
- #3of 10Household and personal products stocks with the fastest earnings growth
- #5of 15Household and personal products stocks with the highest profit margins
- #6of 11Household and personal products stocks with the lowest PE ratio
- #9of 15Household and personal products stocks with the highest free cash flow yield
Its groups
About
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .